Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Li Qin

4PUBLICATIONS

13CO-AUTHORS

Molecular targetsChemical engineering design

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jan 14, 2026

EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge.

Christopher F Bassil, Kerry Dillon, Gray R Anderson

|Aug 19, 2022

Reply to: Target expression is a relevant factor in synthetic lethal screens.

Yosi Gilad, Yossi Eliaz, Yang Yu

|Jul 26, 2021

Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.

Li Qin, Jianwei Chen, Dong Lu

|Mar 26, 2021

A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.

Yosi Gilad, Yossi Eliaz, Yang Yu

Pageof 1

Frequent Collaborators

2 joint publications

San Jung Han

2 joint publications

Bert W O'Malley

2 joint publications

David M Lonard

1 joint publications

Christopher F Bassil

1 joint publications

Jacob P Hoj

1 joint publications

Christian Cerda-Smith

1 joint publications

Haley M Hutchinson

1 joint publications

Shane T Killarney

1 joint publications

Guillaume Robert

1 joint publications

Liron Bar-Peled

Frequent Collaborators

2 joint publications

San Jung Han

2 joint publications

Bert W O'Malley

2 joint publications

David M Lonard

1 joint publications

Christopher F Bassil

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

See more related videos